IL136689A0 - Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists - Google Patents
Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonistsInfo
- Publication number
- IL136689A0 IL136689A0 IL13668998A IL13668998A IL136689A0 IL 136689 A0 IL136689 A0 IL 136689A0 IL 13668998 A IL13668998 A IL 13668998A IL 13668998 A IL13668998 A IL 13668998A IL 136689 A0 IL136689 A0 IL 136689A0
- Authority
- IL
- Israel
- Prior art keywords
- beta
- carboxyl substituted
- derivatives useful
- chroman derivatives
- adrenoreceptor agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Detergent Compositions (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99462097A | 1997-12-19 | 1997-12-19 | |
| PCT/US1998/026735 WO1999032476A1 (en) | 1997-12-19 | 1998-12-16 | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL136689A0 true IL136689A0 (en) | 2001-06-14 |
Family
ID=25540853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13668998A IL136689A0 (en) | 1997-12-19 | 1998-12-16 | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1040106B1 (hu) |
| JP (1) | JP2001526282A (hu) |
| KR (1) | KR20010033188A (hu) |
| CN (1) | CN1284952A (hu) |
| AT (1) | ATE222901T1 (hu) |
| AU (1) | AU749097B2 (hu) |
| BG (1) | BG104593A (hu) |
| BR (1) | BR9814302A (hu) |
| CA (1) | CA2316971A1 (hu) |
| DE (1) | DE69807523T2 (hu) |
| DK (1) | DK1040106T3 (hu) |
| ES (1) | ES2183434T3 (hu) |
| HU (1) | HUP0004565A3 (hu) |
| ID (1) | ID26524A (hu) |
| IL (1) | IL136689A0 (hu) |
| NO (1) | NO20003083L (hu) |
| NZ (1) | NZ505200A (hu) |
| PL (1) | PL341229A1 (hu) |
| PT (1) | PT1040106E (hu) |
| RU (1) | RU2223269C2 (hu) |
| SK (1) | SK9362000A3 (hu) |
| TR (1) | TR200001927T2 (hu) |
| UA (1) | UA62993C2 (hu) |
| WO (1) | WO1999032476A1 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR035605A1 (es) * | 2000-12-11 | 2004-06-16 | Bayer Corp | Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores |
| AR035858A1 (es) * | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
| JPWO2003033468A1 (ja) * | 2001-10-17 | 2005-02-03 | 株式会社カネカ | （Ｓ）−α−ハロメチルピリジンメタノール誘導体の製造方法 |
| MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| CA2597616A1 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| US7560575B2 (en) * | 2005-12-28 | 2009-07-14 | Acino Pharma Ag | Process for preparation of racemic Nebivolol |
| EP1803716B1 (en) * | 2005-12-28 | 2012-07-25 | Acino Pharma AG | A process for preparation of racemic nebivolol |
| ES2534318B1 (es) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Derivados de cromeno sustituidos por alcóxido como inhibidores de la interacción TCR-Nck |
| ES2534336B1 (es) * | 2013-10-18 | 2016-01-28 | Artax Biopharma Inc. | Derivados de cromeno como inhibidores de la interacción TCR-Nck |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1337429C (en) * | 1983-12-05 | 1995-10-24 | Guy Rosalia Eugene Van Lommen | Derivatives of 2,2'-iminobisethanol |
| GB8801306D0 (en) * | 1988-01-21 | 1988-02-17 | Ici Plc | Chemical compounds |
| US5451677A (en) * | 1993-02-09 | 1995-09-19 | Merck & Co., Inc. | Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity |
| DE69404039T2 (de) * | 1993-06-14 | 1997-10-16 | Pfizer | Zweite amine als antidiabetische mittel und für die behandlung von fettleibigkeit |
| GB9405019D0 (en) * | 1994-03-15 | 1994-04-27 | Smithkline Beecham Plc | Novel compounds |
| US5561142A (en) * | 1994-04-26 | 1996-10-01 | Merck & Co., Inc. | Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity |
| EP0801060A1 (en) * | 1996-04-09 | 1997-10-15 | Pfizer Inc. | Heterocyclic Beta-3 Adrenergenic Agonists |
-
1998
- 1998-12-16 SK SK936-2000A patent/SK9362000A3/sk unknown
- 1998-12-16 CN CN98813619A patent/CN1284952A/zh active Pending
- 1998-12-16 WO PCT/US1998/026735 patent/WO1999032476A1/en not_active Application Discontinuation
- 1998-12-16 KR KR1020007006572A patent/KR20010033188A/ko not_active Application Discontinuation
- 1998-12-16 CA CA002316971A patent/CA2316971A1/en not_active Abandoned
- 1998-12-16 AT AT98963240T patent/ATE222901T1/de not_active IP Right Cessation
- 1998-12-16 RU RU2000119110/04A patent/RU2223269C2/ru not_active IP Right Cessation
- 1998-12-16 DE DE69807523T patent/DE69807523T2/de not_active Expired - Fee Related
- 1998-12-16 TR TR2000/01927T patent/TR200001927T2/xx unknown
- 1998-12-16 IL IL13668998A patent/IL136689A0/xx unknown
- 1998-12-16 PL PL98341229A patent/PL341229A1/xx not_active Application Discontinuation
- 1998-12-16 BR BR9814302-6A patent/BR9814302A/pt not_active IP Right Cessation
- 1998-12-16 EP EP98963240A patent/EP1040106B1/en not_active Expired - Lifetime
- 1998-12-16 DK DK98963240T patent/DK1040106T3/da active
- 1998-12-16 ES ES98963240T patent/ES2183434T3/es not_active Expired - Lifetime
- 1998-12-16 JP JP2000525413A patent/JP2001526282A/ja not_active Withdrawn
- 1998-12-16 ID IDW20001393A patent/ID26524A/id unknown
- 1998-12-16 AU AU18300/99A patent/AU749097B2/en not_active Ceased
- 1998-12-16 NZ NZ505200A patent/NZ505200A/xx unknown
- 1998-12-16 HU HU0004565A patent/HUP0004565A3/hu unknown
- 1998-12-16 UA UA2000074336A patent/UA62993C2/uk unknown
- 1998-12-16 PT PT98963240T patent/PT1040106E/pt unknown
-
2000
- 2000-06-15 NO NO20003083A patent/NO20003083L/no not_active Application Discontinuation
- 2000-07-11 BG BG104593A patent/BG104593A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1040106B1 (en) | 2002-08-28 |
| NO20003083D0 (no) | 2000-06-15 |
| DE69807523T2 (de) | 2003-01-09 |
| JP2001526282A (ja) | 2001-12-18 |
| HUP0004565A2 (hu) | 2001-08-28 |
| AU1830099A (en) | 1999-07-12 |
| TR200001927T2 (tr) | 2001-06-21 |
| UA62993C2 (en) | 2004-01-15 |
| EP1040106A1 (en) | 2000-10-04 |
| BR9814302A (pt) | 2000-10-10 |
| PT1040106E (pt) | 2002-11-29 |
| NZ505200A (en) | 2002-09-27 |
| DK1040106T3 (da) | 2002-12-02 |
| BG104593A (en) | 2001-09-28 |
| ATE222901T1 (de) | 2002-09-15 |
| ID26524A (id) | 2001-01-11 |
| DE69807523D1 (de) | 2002-10-02 |
| KR20010033188A (ko) | 2001-04-25 |
| HUP0004565A3 (en) | 2002-12-28 |
| CA2316971A1 (en) | 1999-07-01 |
| ES2183434T3 (es) | 2003-03-16 |
| SK9362000A3 (en) | 2001-09-11 |
| NO20003083L (no) | 2000-08-15 |
| PL341229A1 (en) | 2001-03-26 |
| RU2223269C2 (ru) | 2004-02-10 |
| CN1284952A (zh) | 2001-02-21 |
| WO1999032476A1 (en) | 1999-07-01 |
| AU749097B2 (en) | 2002-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200000927T2 (tr) | Prostaglandin agonistleri ve kemik bozukluklarının tedavisi | |
| YU7797A (sh) | Kombinovana terapija za osteoporozu | |
| AU2962295A (en) | Cannabinoid receptor antagonists | |
| MY121031A (en) | Process for preparing derivatives of the taxoid family | |
| BR9804437A (pt) | Compostos para a osteoporose | |
| AP9801269A0 (en) | Prostaglandin agonists. | |
| ES2189256T3 (es) | Composiciones de mezclas de ester de cianoacrilato. | |
| PT934325E (pt) | Trisanidridos biciclicos de tetrafosfonato | |
| ATE301196T1 (de) | Varianten des menschlichen wachstumshormons | |
| MX9203050A (es) | Compuestos de analogos de triptamina. | |
| EP0896533A4 (en) | PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS | |
| EP0786995A4 (hu) | ||
| MY120976A (en) | 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines | |
| IL136689A0 (en) | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists | |
| WO2002048134A3 (en) | Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists | |
| ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
| ATE402933T1 (de) | Neue sulfonamid-substituierte chroman-derivate verwendbar als beta 3 adrenorezeptor agonisten | |
| MY107354A (en) | Substituted cyclohexenes as central nervous system agents | |
| MX9703232A (es) | Nuevos antagonistas del receptor muscarinico. | |
| BG104427A (en) | Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis | |
| BG104373A (en) | Polymorphous forms of dofetilide | |
| SI1040106T1 (en) | Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists | |
| MX9707832A (es) | 1-fenil-3-pirazolcarboxilamidas que actuan sobre los receptores de neurotensina. | |
| BG101431A (en) | the 2-(3,5-DIFLUOROPHENYL)-3-(4-(METHYLSULPHONYL)PHENYL-2-CYLOPENTEN-1 -ON APPLICABLE AS COX-2 INHIBITOR | |
| MX9709684A (es) | Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel. |